                         SEQUENCE LISTING

<110>  THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER 
       MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED 
       TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
 
<120>  A Method for the Treatment and/or Reduction of Inflammation

<130>  P111825PC00

<150>  EP14185397.8
<151>  2014-09-18

<160>  33    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  1

Asn Pro Gln Arg Glu Ala Pro Pro 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  2

Gly Arg Ala Val Tyr Gln Ser Met 
1               5               


<210>  3
<211>  474
<212>  DNA
<213>  Homo sapiens

<400>  3
atgaacccac aacgggaggc agcacccaaa tcctatgcta ttcgtgattc tcgacagatg       60

gtgtgggtcc tgagtggaaa ttctttaata gcagctcctc ttagccgcag cattaagcct      120

gtcactcttc atttaatagc ctgtagagac acagaattca gtgacaagga aaagggtaat      180

atggtttacc tgggaatcaa gggaaaagat ctctgtctct tctgtgcaga aattcagggc      240

aagcctactt tgcagcttaa ggaaaaaaat atcatggacc tgtatgtgga gaagaaagca      300

cagaagccct ttctcttttt ccacaataaa gaaggctcca cttctgtctt tcagtcagtc      360

tcttaccctg gctggttcat agccacctcc accacatcag gacagcccat ctttctcacc      420

aaggagagag gcataactaa taacactaac ttctacttag attctgtgga ataa            474


<210>  4
<211>  157
<212>  PRT
<213>  Homo sapiens

<400>  4

Met Asn Pro Gln Arg Glu Ala Ala Pro Lys Ser Tyr Ala Ile Arg Asp 
1               5                   10                  15      


Ser Arg Gln Met Val Trp Val Leu Ser Gly Asn Ser Leu Ile Ala Ala 
            20                  25                  30          


Pro Leu Ser Arg Ser Ile Lys Pro Val Thr Leu His Leu Ile Ala Cys 
        35                  40                  45              


Arg Asp Thr Glu Phe Ser Asp Lys Glu Lys Gly Asn Met Val Tyr Leu 
    50                  55                  60                  


Gly Ile Lys Gly Lys Asp Leu Cys Leu Phe Cys Ala Glu Ile Gln Gly 
65                  70                  75                  80  


Lys Pro Thr Leu Gln Leu Lys Glu Lys Asn Ile Met Asp Leu Tyr Val 
                85                  90                  95      


Glu Lys Lys Ala Gln Lys Pro Phe Leu Phe Phe His Asn Lys Glu Gly 
            100                 105                 110         


Ser Thr Ser Val Phe Gln Ser Val Ser Tyr Pro Gly Trp Phe Ile Ala 
        115                 120                 125             


Thr Ser Thr Thr Ser Gly Gln Pro Ile Phe Leu Thr Lys Glu Arg Gly 
    130                 135                 140                 


Ile Thr Asn Asn Thr Asn Phe Tyr Leu Asp Ser Val Glu 
145                 150                 155         


<210>  5
<211>  510
<212>  DNA
<213>  Homo sapiens

<400>  5
atgagaggca ctccaggaga cgctgatggt ggaggaaggg ccgtctatca atcaatgtgt       60

aaacctatta ctgggactat taatgatttg aatcagcaag tgtggaccct tcagggtcag      120

aaccttgtgg cagttccacg aagtgacagt gtgaccccag tcactgttgc tgttatcaca      180

tgcaagtatc cagaggctct tgagcaaggc agaggggatc ccatttattt gggaatccag      240

aatccagaaa tgtgtttgta ttgtgagaag gttggagaac agcccacatt gcagctaaaa      300

gagcagaaga tcatggatct gtatggccaa cccgagcccg tgaaaccctt ccttttctac      360

cgtgccaaga ctggtaggac ctccaccctt gagtctgtgg ccttcccgga ctggttcatt      420

gcctcctcca agagagacca gcccatcatt ctgacttcag aacttgggaa gtcatacaac      480

actgcctttg aattaaatat aaatgactga                                       510


<210>  6
<211>  169
<212>  PRT
<213>  Homo sapiens

<400>  6

Met Arg Gly Thr Pro Gly Asp Ala Asp Gly Gly Gly Arg Ala Val Tyr 
1               5                   10                  15      


Gln Ser Met Cys Lys Pro Ile Thr Gly Thr Ile Asn Asp Leu Asn Gln 
            20                  25                  30          


Gln Val Trp Thr Leu Gln Gly Gln Asn Leu Val Ala Val Pro Arg Ser 
        35                  40                  45              


Asp Ser Val Thr Pro Val Thr Val Ala Val Ile Thr Cys Lys Tyr Pro 
    50                  55                  60                  


Glu Ala Leu Glu Gln Gly Arg Gly Asp Pro Ile Tyr Leu Gly Ile Gln 
65                  70                  75                  80  


Asn Pro Glu Met Cys Leu Tyr Cys Glu Lys Val Gly Glu Gln Pro Thr 
                85                  90                  95      


Leu Gln Leu Lys Glu Gln Lys Ile Met Asp Leu Tyr Gly Gln Pro Glu 
            100                 105                 110         


Pro Val Lys Pro Phe Leu Phe Tyr Arg Ala Lys Thr Gly Arg Thr Ser 
        115                 120                 125             


Thr Leu Glu Ser Val Ala Phe Pro Asp Trp Phe Ile Ala Ser Ser Lys 
    130                 135                 140                 


Arg Asp Gln Pro Ile Ile Leu Thr Ser Glu Leu Gly Lys Ser Tyr Asn 
145                 150                 155                 160 


Thr Ala Phe Glu Leu Asn Ile Asn Asp 
                165                 


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrepeptide

<400>  7

Ala Phe Leu Phe 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  8

Asp Thr Glu Phe 
1               


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Ac

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is AMC

<400>  9

Xaa Asp Glu Val Asp Xaa 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Ac

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is AMC

<400>  10

Xaa Trp Glu His Asp Xaa 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Suc(oMe)

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is AMC

<400>  11

Xaa Ala Ala Pro Val Xaa 
1               5       


<210>  12
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-17C Forward

<400>  12
ttggaggcag acacccacc                                                    19


<210>  13
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-17C Reverse

<400>  13
gatagcggtc ctcatccgtg                                                   20


<210>  14
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-36  Forward

<400>  14
gaaacccttc cttttctacc gtg                                               23


<210>  15
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-36  Reverse

<400>  15
gctggtctct cttggaggag                                                   20


<210>  16
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-8 Forward

<400>  16
tctgcagctc tgtgtgaagg                                                   20


<210>  17
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IL-8 Reverse

<400>  17
acttctccac aaccctctga                                                   20


<210>  18
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  G-CSF Forward

<400>  18
gcttagagca agtgaggaag                                                   20


<210>  19
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  G-CSF Reverse

<400>  19
aggtggcgta gaacgcggta                                                   20


<210>  20
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  GM-CSF Forward

<400>  20

Gly Ala Gly Cys Ala Thr Gly Thr Gly Ala Ala Thr Gly Cys Cys Ala 
1               5                   10                  15      


Thr Cys Cys Ala Gly Gly Ala Gly 
            20                  


<210>  21
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GM-CSF Reverse

<400>  21
ctcctggact ggctcccagc agtcaaa                                           27


<210>  22
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>   beta-defensin-2 Forward

<400>  22
atgagggtct tgtatctcct                                                   20


<210>  23
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  beta -defensin-2 Reverse

<400>  23
tatctttgga caccatagtt                                                   20


<210>  24
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  beta-Actin Forward

<400>  24
atgtttgaga ccttcaacac                                                   20


<210>  25
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  beta-Actin Reverse

<400>  25
cacgtcacac ttcatgatgg                                                   20


<210>  26
<211>  477
<212>  DNA
<213>  Homo sapiens

<400>  26
atggaaaaag cattgaaaat tgacacacct cagcagggga gcattcagga tatcaatcat       60

cgggtgtggg ttcttcagga ccagacgctc atagcagtcc cgaggaagga ccgtatgtct      120

ccagtcacta ttgccttaat ctcatgccga catgtggaga cccttgagaa agacagaggg      180

aaccccatct acctgggcct gaatggactc aatctctgcc tgatgtgtgc taaagtcggg      240

gaccagccca cactgcagct gaaggaaaag gatataatgg atttgtacaa ccaacccgag      300

cctgtgaagt cctttctctt ctaccacagc cagagtggca ggaactccac cttcgagtct      360

gtggctttcc ctggctggtt catcgctgtc agctctgaag gaggctgtcc tctcatcctt      420

acccaagaac tggggaaagc caacactact gactttgggt taactatgct gttttaa         477


<210>  27
<211>  158
<212>  PRT
<213>  Homo sapiens

<400>  27

Met Glu Lys Ala Leu Lys Ile Asp Thr Pro Gln Gln Gly Ser Ile Gln 
1               5                   10                  15      


Asp Ile Asn His Arg Val Trp Val Leu Gln Asp Gln Thr Leu Ile Ala 
            20                  25                  30          


Val Pro Arg Lys Asp Arg Met Ser Pro Val Thr Ile Ala Leu Ile Ser 
        35                  40                  45              


Cys Arg His Val Glu Thr Leu Glu Lys Asp Arg Gly Asn Pro Ile Tyr 
    50                  55                  60                  


Leu Gly Leu Asn Gly Leu Asn Leu Cys Leu Met Cys Ala Lys Val Gly 
65                  70                  75                  80  


Asp Gln Pro Thr Leu Gln Leu Lys Glu Lys Asp Ile Met Asp Leu Tyr 
                85                  90                  95      


Asn Gln Pro Glu Pro Val Lys Ser Phe Leu Phe Tyr His Ser Gln Ser 
            100                 105                 110         


Gly Arg Asn Ser Thr Phe Glu Ser Val Ala Phe Pro Gly Trp Phe Ile 
        115                 120                 125             


Ala Val Ser Ser Glu Gly Gly Cys Pro Leu Ile Leu Thr Gln Glu Leu 
    130                 135                 140                 


Gly Lys Ala Asn Thr Thr Asp Phe Gly Leu Thr Met Leu Phe 
145                 150                 155             


<210>  28
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  28

Met Glu Lys Ala Leu Lys Ile Asp 
1               5               


<210>  29
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  29

Met Ala Leu Ala 
1               


<210>  30
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  30

Asn Pro Gln Arg 
1               


<210>  31
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  31

Gln Arg Glu Ala 
1               


<210>  32
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  32

Gly Arg Ala Val 
1               


<210>  33
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  33

Ala Val Tyr Gln 
1               


